Skip to main content
GutCited

Alpha-Galactosidase için Bloating and Intestinal Gas

B

Reduces gas symptoms from high-fiber foods containing raffinose/stachyose by 50-70%. Beano (alpha-galactosidase 300 GalU) is the most studied formulation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dalpha\u002Dgalactosidase\u0026condition\u003Dbloating\u002Dand\u002Dgas'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Reduces gas symptoms from high-fiber foods containing raffinose/stachyose by 50-70%. Beano (alpha-galactosidase 300 GalU) is the most studied formulation.

Key Study Findings

Review
Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Randomized Controlled Trial Double-blind
A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal …
Dose: 1200 G vs: placebo Outcome: every 30 min during 7 Etki: None None

Popülasyon: patients with ibs after three standardized

Other n=17
FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.
Dose: None vs: no treatment Outcome: None Etki: None None

Popülasyon: fabry disease but are often nonspecific

Randomized Controlled Trial n=31 2.0 weeks Double-blind
Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.
Dose: 300 GALU or 150 GALU vs: Placebo (glucose) Outcome: GI symptom severity on VAS Etki: None pP0.006

Popülasyon: IBS patients (Rome III, H2 producers)

Randomized Controlled Trial n=125 4 weeks Double-blind
Does oral α-galactosidase relieve irritable bowel symptoms?
Dose: alpha-galactosidase 600 GalU per meal vs: placebo Outcome: overall IBS symptom relief Etki: no significant difference vs placebo >0.05

Popülasyon: IBS patients

Case Reports
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha …
Dose: 3.7nmol/mL/h vs: None Outcome: None Etki: None None

Popülasyon: patients

Key Statistics

4

Çalışmalar

300

Katılımcılar

Positive

B

Derece

Referenced Papers

Scandinavian journal of … 2016 17 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
150-300 GalU (alpha-galactosidase units) per serving of gas-producing foods
standardbeanodose:
300 GalU (2-3 tablets) with first bite of problem food

Üst sınır: No established upper limit; adjust per meal as needed

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Mixed --
1200 G -- Neutral --
None -- Positive 17
300 GALU or 150 GALU 2.0 weeks Positive 31
alpha-galactosidase 600 GalU per meal 4 weeks Neutral 125
3.7nmol/mL/h -- Mixed --
None 2 weeks Positive --
300 or 1200 GalU -- Positive 8

En iyi alım zamanı: With the first bite of gas-producing food

Safety & Side Effects

Bildirilen Yan Etkiler

  • Generally very well-tolerated
  • Rare allergic reactions to mold-derived enzyme (Aspergillus source)
  • May cause mild GI discomfort in rare cases

Bilinen Etkileşimler

  • Acarbose (alpha-galactosidase may counteract the blood sugar-lowering mechanism of acarbose; contraindicated for concurrent use)
  • Miglitol (similar mechanism conflict as acarbose)

Tolere edilebilir üst alım: No established upper limit; adjust per meal as needed

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Alpha-Galactosidase help with Bloating and Intestinal Gas?
Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Alpha-Galactosidase may support Bloating and Intestinal Gas management. Our evidence grade is B (Good Evidence).
How much Alpha-Galactosidase should I take for Bloating and Intestinal Gas?
Studies have used various dosages. A commonly studied range is 150-300 GalU (alpha-galactosidase units) per serving of gas-producing foods. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Alpha-Galactosidase?
Reported side effects may include Generally very well-tolerated, Rare allergic reactions to mold-derived enzyme (Aspergillus source), May cause mild GI discomfort in rare cases. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Alpha-Galactosidase and Bloating and Intestinal Gas?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Alpha-Galactosidase diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.